Almost all articles on cancer prognostic markers report statistically significant results.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Journal of Cancer

• Publication date

  2007-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.EJCA.2007.08.030PMID 17981458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular evidence‐based medicine

  2007cited by this paper
• Selection in Reported Epidemiological Risks: An Empirical Assessment

  2007cited by this paper
• An exploratory test for an excess of significant findings

  2007cited by this paper
• Is molecular profiling ready for use in clinical decision making?

  2007cited by this paper
• Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect.

  2007cited by this paper
• A road map for efficient and reliable human genome epidemiology

  2006cited by this paper
• The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma.

  2006cited by this paper
• Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer--mature results for medically inoperable patients.

  2006cited by this paper
• Prognostic relevance of CD56 expression in multiple myeloma: A study including 107 cases treated with high-dose melphalan-based chemotherapy and autologous stem cell transplant

  2006cited by this paper
• Expression and prognostic significance of hypoxia-inducible factor 1α (HIF-1α) in malignant pleural mesothelioma (MPM)

  2006cited by this paper
• Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer

  2006cited by this paper
• Expression and prognostic significance of hypoxia-inducible factor 1alpha (HIF-1alpha) in malignant pleural mesothelioma (MPM).

  2006cited by this paper
• Survivin expression and its clinical significance in pancreatic cancer

  2005cited by this paper
• Positive Microscopic Margins Alter Outcome in Lymph Node-Negative Cholangiocarcinoma When Resection Is Combined With Adjuvant Radiotherapy

  2005cited by this paper
• Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme.

  2005cited by this paper
• BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival.

  2005cited by this paper
• Body mass index and the risk of male cancer mortality of various sites: 17-year follow-up of the Basel cohort study.

  2005cited by this paper
• Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology Group.

  2005cited by this paper
• Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy

  2005cited by this paper
• Why Most Published Research Findings Are False

  2005cited by this paper
• Apoptosis of lymphocytes in peripheral blood of patients with melanoma

  2005cited by this paper
• Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.

  2005cited by this paper
• Bcl‐2 protein and DNA ploidy in renal cell carcinoma: Do they affect patient prognosis?

  2005cited by this paper
• Serum p53 antibodies in drainage blood from the azygos vein in patients with esophageal carcinoma.

  2005cited by this paper
• Cyclooxygenase-2 (COX-2) Levels Before and After Chemotherapy: A Study in Rectal Cancer

  2005cited by this paper
• Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas.

  2005cited by this paper
• Clinicopathological correlation between expression of PTHrP receptor and various prognostic factors in breast cancer without axillary lymph node metastasis.

  2005cited by this paper
• TGF-α, c-erbB-2 Expression and Neoangiogenesis in Vulvar Squamous Cell Carcinoma

  2005cited by this paper
• Interferon γ and tumour necrosis factor α in relation to anaemia and prognosis in childhood cancer

  2005cited by this paper
• Loss of basement membrane heparan sulfate expression is associated with tumor progression in endometrial cancer.

  2005cited by this paper
• Functional outcomes and survival in patients with high-grade gliomas in dominant and nondominant hemispheres.

  2005cited by this paper
• A lack of prognostic significance regarding DeltaNp63 immunoreactivity in lung cancer.

  2005cited by this paper
• P53 Mutation Analysis of Colorectal Liver Metastases: Relation to Actual Survival, Angiogenic Status, and p53 Overexpression

  2005cited by this paper
• FGFR3 and Tp53 Mutations in T1G3 Transitional Bladder Carcinomas: Independent Distribution and Lack of Association with Prognosis

  2005cited by this paper
• VEGF and Its Receptors (flt-1 and KDR/flk-1) as Prognostic Indicators in Endometrial Carcinoma

  2005cited by this paper
• Clinical evaluation of serum p53 antibodies in patients with upper urinary tract tumors.

  2005cited by this paper
• p16 gene methylation lacks correlation with angiogenesis and prognosis in multiple myeloma.

  2005cited by this paper
• Expression of Ki‐67 in squamous cell carcinoma of the penis

  2005cited by this paper
• In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis

  2005cited by this paper
• Endostatin Polymorphism 4349G/A(D104N) is not Associated with Aggressiveness of Disease in Postate Cancer

  2005cited by this paper
• Personality and cancer survival: the Miyagi cohort study

  2005cited by this paper
• Chromosomal Changes in relation to Clinical Outcome in Larynx and Pharynx Squamous Cell Carcinoma

  2005cited by this paper
• Prognostic Significance of Vascular Endothelial Growth Factor Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis

  2005cited by this paper
• Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.

  2005cited by this paper
• REporting recommendations for tumor MARKer prognostic studies (REMARK)

  2005cited by this paper
• TGF-alpha, c-erbB-2 expression and neoangiogenesis in vulvar squamous cell carcinoma.

  2005cited by this paper
• Serum PDGF-AB in Pleural Mesothelioma

  2005cited by this paper
• Nuclear beta-catenin expression is rare and its potential association with short survival in colorectal signet-ring cell carcinoma.

  2005cited by this paper
• P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications.

  2005cited by this paper
• The degree of bone marrow fibrosis in chronic myelogenous leukemia is not a prognostic factor with imatinib mesylate therapy

  2005cited by this paper
• Nuclear β-Catenin Expression Is Rare and its Potential Association With Short Survival in Colorectal Signet-Ring Cell Carcinoma

  2005cited by this paper
• Overexpression of Cyclooxygenase-2 Is Associated with a Favorable Prognostic Phenotype in Breast Carcinoma

  2005cited by this paper
• Immunohistochemical Analysis of Platelet-derived Growth Factor Receptor-α, -β, c-kit, c-abl, and Arg Proteins in Glioblastoma: Possible Implications for Patient Selection for Imatinib Mesylate Therapy

  2005cited by this paper
• Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma.

  2005cited by this paper
• P53 Alteration in Oral Tongue Cancer is Not Significantly Associated with Age at Diagnosis or Tobacco Exposure

  2005cited by this paper
• Oral squamous cell carcinoma. Cytometric parameters of prognostic interest.

  2005cited by this paper
• P53, bcl-2 and Ki-67 expression in adenoid cystic carcinoma of the palate. A clinico-pathologic study of 21 cases with long-term follow-up.

  2005cited by this paper
• High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer.

  2005cited by this paper
• Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.

  2005cited by this paper
• Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?

  2005cited by this paper
• Binding of recombinant mistletoe lectin (aviscumine) to resected human adenocarcinoma of the lung.

  2005cited by this paper
• Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy: influenced by the HER2- and Topoisomerase IIα-status of the primary tumor?

  2005cited by this paper
• Selective reporting biases in cancer prognostic factor studies.

  2005influential reference
• Prognostic Significance of DCC and p27Kip1 in Colorectal Cancer

  2005cited by this paper
• MDM2 as a predictor of prostate carcinoma outcome

  2005cited by this paper
• Prognostic importance of COX-2 expression in patients with colorectal cancer.

  2005cited by this paper
• The Effect of Apoptotic Activity, Survivin, Ki-67, and P-glycoprotein Expression on Prognosis in Pancreatic Carcinoma

  2005cited by this paper
• Molecular markers in gastric cancer: can p53 and bcl-2 protein expressions be used as prognostic factors?

  2005cited by this paper
• Minor morphologic abnormalities of adrenal glands at CT: prognostic importance in patients with lung cancer.

  2005cited by this paper
• Clinical trial registration: a statement from the International Committee of Medical Journal Editors.

  2005cited by this paper
• The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: A retrospective study of 295 newly diagnosed patients by the Children's Oncology Group

  2005cited by this paper
• Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases.

  2005cited by this paper
• Assessment of staging, prognosis and mortality of colorectal cancer by tumor markers: receptor erbB-2 and cadherins.

  2005cited by this paper
• Soyfood intake and breast cancer survival: a followup of the Shanghai Breast Cancer Study

  2005cited by this paper
• REporting recommendations for tumour MARKer prognostic studies (REMARK).

  2005cited by this paper
• E-cadherin and fibronectin expressions have no prognostic role in stage II ductal breast cancer.

  2005cited by this paper
• The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.

  2005cited by this paper
• Methodological challenges in the evaluation of prognostic factors in breast cancer

  2004cited by this paper
• P53 expression in colorectal carcinoma: the University of Malaya Medical Centre's experience.

  2004cited by this paper
• Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

  2004cited by this paper
• Assessing the probability that a positive report is false: an approach for molecular epidemiology studies.

  2004cited by this paper
• Prognostic Significance of TP53 Tumor Suppressor Gene Expression and Mutations in Human Osteosarcoma

  2004cited by this paper
• [Prognostic value of c-erb-2 immunohistochemistry expression in patients with primary breast cancer and adjuvant treatment with tamoxifen].

  2004cited by this paper
• FHIT expression in neoplastic, hyperplastic, and normal endometrium

  2004cited by this paper
• An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods.

  2004cited by this paper
• Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research

  2004cited by this paper
• Clinical trial registration: a statement from the International Committee of Medical Journal Editors.

  2004cited by this paper
• Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines

  2004cited by this paper
• Developing optimal search strategies for detecting clinically sound prognostic studies in MEDLINE: an analytic survey

  2004cited by this paper
• The association of P‐glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma

  2003cited by this paper
• Tumor markers as clinical cancer tests--are we there yet?

  2002cited by this paper
• Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas

  2002cited by this paper
• Introduction: Tumor markers as clinical cancer tests—are we there yet?

  2002cited by this paper
• 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.

  2001cited by this paper
• Systematic reviews of evaluations of prognostic variables

  2001cited by this paper
• Over-expression of p53 and c-erbB-2 oncoproteins in laryngeal carcinoma

  2001cited by this paper
• Minimum information about a microarray experiment (MIAME)—toward standards for microarray data

  2001cited by this paper
• The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response

  2001cited by this paper
• Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study.

  2000cited by this paper
• Assessment of tumor angiogenesis in invasive breast carcinomas: absence of correlation with prognosis and pathological factors

  2000cited by this paper

• Sex as a prognostic factor for mortality in adults with acute symptomatic pulmonary embolism.

  2025cites this paper
• Ending publication bias: A values-based approach to surface null and negative results

  2025cites this paper
• A reusable and batch-produced SERS platform for label-free detection of kidney stones in urine

  2025cites this paper
• Soluble urokinase plasminogen activator receptor and perioperative complications: a systematic review

  2025cites this paper
• Publication bias is bad for science if not necessarily scientists

  2025cites this paper
• Detection of hyaluronidase in urine using hyaluronic acid-coated silver nanoparticles-based surface-enhanced Raman spectroscopy for the diagnosis of bladder cancer.

  2025cites this paper
• The challenges for developing prognostic prediction models for acute kidney injury in hospitalized children: A systematic review

  2024cites this paper
• The role of randomized controlled trials, registries, observational databases in evaluating new interventions.

  2023cites this paper
• From Methods to Monographs: Fostering a Culture of Research Quality

  2023cites this paper
• Prognostic and Clinicopathological Significance of Epidermal Growth Factor Receptor (EGFR) Expression in Oral Squamous Cell Carcinoma: Systematic Review and Meta-Analysis

  2023cites this paper
• Predictive value of CDKN2A/p16INK4a expression in the malignant transformation of oral potentially malignant disorders: Systematic review and meta-analysis.

  2023cites this paper
• Statistical significance and publication reporting bias in abstracts of reproductive medicine studies

  2023cites this paper
• Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: A systematic review and meta-analysis.

  2022cites this paper
• Risk of Dementia in Cancer Survivors: A Meta-Analysis of Population-Based Cohort Studies

  2022cites this paper
• Do we need audiogram-based prescriptions? A systematic review

  2022cites this paper
• Prognostic and Clinicopathological Significance of Telomerase Reverse Transcriptase Upregulation in Oral Cancer: A Systematic Review and Meta-Analysis

  2022cites this paper
• Structured reporting to improve transparency of analyses in prognostic marker studies

  2022cites this paper
• Design and methodological characteristics of studies using observational routinely collected health data for investigating the link between cancer and neurodegenerative diseases: protocol for a meta-research study

  2022cites this paper
• Prognostic and Clinicopathological Significance of the Aberrant Expression of β-Catenin in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

  2022cites this paper
• Improving the Quality of Radiofrequency Bioeffects Research: The Need for a Carrot and a Stick

  2021cites this paper
• Does Probe-Tube Verification of Real-Ear Hearing Aid Amplification Characteristics Improve Outcomes in Adults? A Systematic Review and Meta-Analysis

  2021cites this paper
• Retrospective cohort study evaluating clinical, biochemical and pharmacological prognostic factors for prostate cancer progression using primary care data

  2021cites this paper
• Bacteria and bioburden and healing in complex wounds: A prognostic systematic review

  2021cites this paper
• Sex as a prognostic factor for mortality in adults with acute symptomatic pulmonary embolism

  2021cites this paper
• Association Between Estrogen Receptors and GATA3 in Bladder Cancer: A Systematic Review and Meta-Analysis of Their Clinicopathological Significance

  2021cites this paper
• Trends in Publication of Negative Studies in Prominent Indian Medical Journals

  2021cites this paper
• Clinicopathological and prognostic characteristics of oral squamous cell carcinomas arising in patients with oral lichen planus: A systematic review and a comprehensive meta-analysis.

  2020cites this paper
• Pre-Clinical Common Data Elements for Traumatic Brain Injury Research: Progress and Use Cases

  2020cites this paper
• Doug Altman: Driving critical appraisal and improvements in the quality of methodological and medical research

  2020cites this paper
• Inflammatory indexes are not associated with sarcopenia in Chinese community-dwelling older people: a cross-sectional study

  2020cites this paper
• Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer

  2020cites this paper
• Management of the cN0 neck in early oral cancer: time to revise the guidance?

  2020cites this paper
• Use of GRADE for assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks.

  2020cites this paper
• Real Life Outcomes vs. Clinical Trial Results

  2019cites this paper
• Predictive value of CCND1/cyclin D1 alterations in the malignant transformation of potentially malignant head and neck disorders: Systematic review and meta‐analysis

  2019cites this paper
• A guide to systematic review and meta-analysis of prognostic factor studies

  2019cites this paper
• Increase value and reduce waste in research on psychological therapies.

  2019cites this paper
• Understanding of researcher behavior is required to improve data reliability

  2019cites this paper
• Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review

  2018cites this paper
• Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review

  2018cites this paper
• Additional value of EUS in oesophageal cancer patients staged N0 on PET/CT: validation of a prognostic model

  2018cites this paper
• Factors influencing choice of health system access level in China: A systematic review

  2018cites this paper
• Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT

  2018cites this paper
• Prognostic and clinicopathological significance of cyclin D1 expression in oral squamous cell carcinoma: A systematic review and meta-analysis.

  2018cites this paper
• Prognostic and clinicopathological significance of CTTN/cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta‐analysis

  2018cites this paper
• Systematic review of the literature on triclosan and health outcomes in humans

  2018cites this paper
• Biomedical Text Mining for Research Rigor and Integrity: Tasks, Challenges, Directions

  2017cites this paper
• Physical activity and cancer: an umbrella review of the literature including 22 major anatomical sites and 770 000 cancer cases

  2017cites this paper
• Clinical trials in dermatology

  2017cites this paper
• Systematic review of prognostic prediction models for acute kidney injury (AKI) in general hospital populations

  2017cites this paper
• CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma

  2017cites this paper
• University of Birmingham Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline?

  2017cites this paper
• Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies

  2017cites this paper
• Reproducibility in biomarker research and clinical development: a global challenge.

  2017cites this paper
• Biomarkers of Renal Cancer

  2017cites this paper
• A systematic review: Childhood cancer survivors and gastrointestinal cancer.

  2017cites this paper
• Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles

  2017cites this paper
• Application of Clinical Trial Results to Clinical Practice.

  2017cites this paper
• Experimental Design for Laboratory Biologists: Maximising Information and Improving Reproducibility. By Stanley E. Lazic. Cambridge and New York: Cambridge University Press. $175.00 (hardcover); $64.99 (paper). xv + 412 p.; ill.; index. ISBN: 978-1-107-07429-3 (hc); 978-1-107-42488-3 (pb); 978-1-316

  2017cites this paper
• Waste, Leaks, and Failures in the Biomarker Pipeline.

  2017cites this paper
• Challenges in Applying the Results of Clinical Trials to Clinical Practice.

  2016cites this paper
• Immune response profiling of malignant pleural mesothelioma for diagnostic and prognostic biomarkers

  2016cites this paper
• Science in the UK − whereto now?

  2016cites this paper
• Managing risks in drug discovery: reproducibility of published findings

  2016cites this paper
• The Solution to Science's Replication Crisis

  2016cites this paper
• Randomized trials are frequently fragmented in multiple secondary publications.

  2016cites this paper
• Grant writing for innovative medical research: Time to rethink

  2016cites this paper
• Diet, body size, physical activity and risk of prostate cancer: An umbrella review of the evidence.

  2016cites this paper
• Reporting of Positive Results in Randomized Controlled Trials of Mindfulness-Based Mental Health Interventions

  2016cites this paper
• Assessment of the extent of unpublished studies in prognostic factor research: a systematic review of p53 immunohistochemistry in bladder cancer as an example

  2016cites this paper
• Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis

  2016cites this paper
• Neutrophil‐to‐lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710

  2016cites this paper
• The prognostic utility of tests of platelet function for the detection of 'aspirin resistance' in patients with established cardiovascular or cerebrovascular disease: a systematic review and economic evaluation.

  2015cites this paper
• A review of epidemiologic studies of low-level exposures to organophosphorus insecticides in non-occupational populations

  2015cites this paper
• Hypotheses presence and acceptance in seven soil science journals

  2015cites this paper
• Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients

  2015cites this paper
• Science as a Social Enterprise

  2015cites this paper
• Ethics of Cancer Gene Transfer Clinical Research.

  2015cites this paper
• Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma

  2015cites this paper
• Oral Squamous Cell Carcinoma - Role of the Plasminogen Activation System in Tumour Progression.

  2015cites this paper
• Improving the predictive value of interventional animal models data.

  2015cites this paper
• Facteurs pronostiques et cancers bronchopulmonaires

  2015cites this paper
• Validation of new cancer biomarkers: a position statement from the European group on tumor markers.

  2015cites this paper
• Application of credibility ceilings probes the robustness of meta-analyses of biomarkers and cancer risk.

  2015cites this paper
• Accuracy of bleeding scores for patients presenting with myocardial infarction: a meta-analysis of 9 studies and 13 759 patients

  2015cites this paper
• Genetic Determinism, Technology Optimism, and Race

  2015cites this paper
• Multivariate meta‐analysis of prognostic factor studies with multiple cut‐points and/or methods of measurement

  2015cites this paper
• Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies

  2015cites this paper
• Atrazine and Pregnancy Outcomes: A Systematic Review of Epidemiologic Evidence

  2014cites this paper
• Public health applications of cardiovascular genomics

  2014cites this paper
• Prognostic value of circulating cytokines on overall survival and disease-free survival in cancer patients.

  2014cites this paper
• Big Data and Large Sample Size: A Cautionary Note on the Potential for Bias

  2014cites this paper
• The reproducibility of biomedical research: Sleepers awake!

  2014cites this paper
• Predicting chemotherapy-induced febrile neutropenia outcomes in adult cancer patients: an evidence-based prognostic model.

  2014cites this paper
• The time has come to register diagnostic and prognostic research.

  2014cites this paper
• A Matter of Accuracy. Nanobiochips in Diagnostics and in Research: Ethical Issues as Value Trade-Offs

  2014cites this paper
• Do phthalates act as obesogens in humans? A systematic review of the epidemiological literature

  2014cites this paper
• Improving the Transparency of Prognosis Research: The Role of Reporting, Data Sharing, Registration, and Protocols

  2014cites this paper
• Replication and exploratory analysis of 24 candidate risk polymorphisms for neural tube defects

  2014cites this paper
• Biomedical research: increasing value, reducing waste.

  2014cites this paper